| P50 | author | Stephen Duffull | Q46819544 |
| P2093 | author name string | David W Johnson | |
| | Stacey O'Shea | |
| P2860 | cites work | Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections | Q54297609 |
| | Adaptive resistance to aminoglycoside antibiotics from first-exposure down-regulation. | Q54319060 |
| | Univariate and multivariate analyses of risk factors predisposing to auditory toxicity in patients receiving aminoglycosides | Q28361967 |
| | A suggested approach to once‐daily aminoglycoside dosing | Q34347273 |
| | First-exposure adaptive resistance to aminoglycoside antibiotics in vivo with meaning for optimal clinical use. | Q36752618 |
| | Experience with a once-daily aminoglycoside program administered to 2,184 adult patients | Q39779327 |
| | Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance | Q39828366 |
| | Adaptive resistance following single doses of gentamicin in a dynamic in vitro model. | Q39881843 |
| | The post-antibiotic sub-MIC effect in vitro and in vivo | Q40827407 |
| | Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis | Q40988370 |
| | Single daily dosing of aminoglycosides in immunocompromised adults: a systematic review | Q41463791 |
| | Single or multiple daily doses of aminoglycosides: a meta-analysis | Q42145555 |
| | Risk Factors for Nephrotoxicity in Patients Treated with Aminoglycosides | Q42247725 |
| | Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration | Q44483617 |
| | Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental pseudomonas pneumonia | Q46611376 |
| | A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides. | Q50509585 |
| | A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides. | Q50509590 |
| | Aminoglycosides: single or multiple daily dosing? A meta-analysis on efficacy and safety. | Q50522237 |
| | Risk factors for the development of auditory toxicity in patients receiving aminoglycosides. | Q50589543 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | renal dialysis | Q202301 |
| P304 | page(s) | 225-230 | |
| P577 | publication date | 2009-04-05 | |
| P1433 | published in | Seminars in Dialysis | Q15761546 |
| P1476 | title | Aminoglycosides in hemodialysis patients: is the current practice of post dialysis dosing appropriate? | |
| P478 | volume | 22 | |